Cardiology Research Review, Issue 163
In this issue:
Microplastics and nanoplastics in atheromas
RNA interference agent zilebesiran for mild to moderate hypertension
Recurrence of AF in patients with new-onset AF after CABG
Cardiovascular outcomes in type 2 diabetics treated with various agents
Direct oral anticoagulants for stroke prevention in patients with device-detected AF
Angiotensin receptor + neprilysin inhibition in patients with STEMI vs NSTEMI
Remoteness does not affect post-MI outcomes in Victoria
Secondary prevention medications in metropolitan vs non-metropolitan areas of Victoria
Concomitant use of SSRIs and oral anticoagulants increases risk of major bleeding
Impact of empagliflozin on heart failure risk after MI
Expert contributor
Associate Professor John Amerena
Assoc Prof John Amerena trained in Melbourne before spending four years in the United States at the University of Michigan. Over that period of time he worked in the fields of hypertension and hyperlipidemia, before returning to Australia where he is now a Cardiologist at Barwon Health. He currently has a joint appointment in the […]
Latest Publications and Videos
Stay up to date with our latest clinical information.
Explore Research Review Publications and Videos
Dive into our publications and videos content from over 50 areas of medicine including Cardiology, Diabetes, Oncology, Haematology and Psychiatry.
Terms and Conditions
Website terms of use
By using our website, you agree to follow these terms and conditions.
Privacy policy
We take your privacy seriously. To understand how we collect, use, and protect your information, please read our Privacy Policy, which is part of these terms.
Copyright and use of website content
The content of our website is protected by copyright, trademarks, and other legal rights. You can: view, download, or print a single copy of content for your personal or professional use.
You cannot: copy, modify, or distribute website content, or use our website content for commercial purposes or in other works without permission.
Links to third-party websites
The Research Review website may link to third-party websites for your convenience. However:
We do not endorse or approve their products, services, or actions.
We are not responsible for their content or how they operate.
There is no formal partnership between us and third parties unless we clearly state otherwise.
Disclaimer and limitation of liability
We do our best to keep the information on our website accurate, but we do not guarantee that it is always correct or up to date.
To the fullest extent allowed by law, we are not responsible for:
Any loss, damage, or costs you may suffer from using (or being unable to use) our website.
Any decisions you make based on the information provided.
Any business losses, such as lost profits, lost data, or business interruptions.
Governing law
These terms are governed by New Zealand law. If there is a dispute, it must be resolved in a New Zealand court.